| 标题 |
[高分]
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP) |
| 网址 | |
| DOI | |
| 其它 |
期刊:JAAD International 作者:K. Duffin; Christopher E. M. Griffiths; Matthias Hoffmann; A. Blauvelt; Y. Balagula; et al 出版日期:2025-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)